z-logo
open-access-imgOpen Access
Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients withBRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore
Author(s) -
David S.P. Tan,
Jack Junjie Chan,
Robert Hettle,
W Ghosh,
A Viswambaram,
Cindy Chen Yu
Publication year - 2021
Publication title -
journal of gynecologic oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.358
H-Index - 37
eISSN - 2005-0399
pISSN - 2005-0380
DOI - 10.3802/jgo.2021.32.e27
Subject(s) - medicine , olaparib , oncology , brca mutation , ovarian cancer , chemotherapy , first line , cancer , gynecology , poly adp ribose polymerase , gene , polymerase , biochemistry , chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom